Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.
about
Do advanced glycation end-products play a role in malaria susceptibility?Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.Viral infection of the lung: host response and sequelaeThe receptor for advanced glycation end products (RAGE) and the lung.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureMacrophage endocytosis of high-mobility group box 1 triggers pyroptosis.Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory studyUsing Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and agingHMGB1 protein binds to influenza virus nucleoprotein and promotes viral replicationInfection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype.Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus.Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia.Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.Human primary airway epithelial cells isolated from active smokers have epigenetically impaired antiviral responsesThe role of receptor for advanced glycation endproducts (RAGE) in infection.Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.Induction of high mobility group box-1 in vitro and in vivo by respiratory syncytial virus.
P2860
Q24471760-A3373BA3-53AE-4DC2-BEB3-990345F5E43DQ30375577-2A7335E9-454B-4966-A772-147C0F315393Q30407392-F12DA116-8362-4D0B-8E9A-D1992010D264Q30409296-054A30B6-1072-4991-9427-EB0B9D484E5BQ33633330-C9D4EB79-53AA-4DD4-8ADD-42CCAC16EF77Q33822512-F2D53C55-A76B-4E81-B782-FEC50260C44CQ33858418-3359E48A-D273-409F-B792-A392363819B3Q33919261-1EFEB6E6-27F4-4CD7-98FF-78F316E7D14CQ33941922-89F03848-13F1-4CC5-8A6F-1E62791677A8Q34094369-94DE2E9C-03D9-4A08-B234-D7FD2928BDA4Q34303782-F32ECE27-9856-4243-9DE8-41D49308021AQ35275358-39B7DF1B-0270-4FFC-A0E2-D49F18B6E3C1Q35363365-439C63D1-4502-4DE1-8BE2-16BDAAE298E8Q35908548-D8A77A3A-9D37-48A9-9BAA-EDD1E6DF2346Q35944988-792D5AFA-BA40-4E89-BB9E-98D46A563262Q37237117-03FF0853-80AD-4E73-A4ED-DE3F277CFEC9Q37860412-82EC1E80-21AA-46C8-9ECD-781765CF5CFEQ37972674-41050898-D86D-41AF-BCD2-52D0C42DD97CQ39700115-B67578A6-541D-4165-BBEC-125259ADBE9DQ42575063-C74E1BC3-ABB6-4497-A113-CA9EDF90838EQ47554353-53D18E98-E161-4035-8C04-3CCBDF0C3391
P2860
Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@ast
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@en
type
label
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@ast
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@en
prefLabel
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@ast
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@en
P2093
P2860
P50
P1433
P1476
Receptor for advanced glycatio ...... g influenza A virus pneumonia.
@en
P2093
Ahmed Achouiti
Angelika Bierhaus
Jennie M Braun-Pater
Koenraad F van der Sluijs
Marieke A D van Zoelen
Peter P Nawroth
P2860
P304
P356
10.1016/J.VIROL.2009.05.032
P407
P577
2009-07-09T00:00:00Z